SJUTS DUSTIN S (Chief Commercial Officer) received a stock award from REVANCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2024ACC: 0001479290-24-000006
Officer· Chief Commercial Officer
Since Dec 2019
+264.00
Net shares
Net buyer
$2.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
264.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+264.00
Price / share
$7.47
Trade value
$1.97K
% of position
0.2%
12/31/2023
157.35K→157.62K
Total
Net shares
+264.00
Net value
$1.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2023 | A · Award | +264.00 | $7.47 | $1.97K | 0.2% | 157.35K | 157.62K |
| Total | +264.00 | $1.97K | ||||||
Derivative Transactions0
No derivative transactions reported